DATA-DRIVEN TIMING OF OPTIMAL LV EJECTION FRACTION ASSESSMENT IN BREAST CANCER PATIENTS EXPOSED TO TRASTUZUMAB
Colin Johnson(University of Iowa Hospitals and Clinics), Jeffrey Sulpher(BC Cancer Agency), Michèle Turek(Ottawa Hospital), Nadine Graham(University of Ottawa), Peter Andrew, H. Majeed
Cited by 0
Related Papers
Combined Angioplasty and Pharmacological Intervention Versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study)
|Journal of the American College of Cardiology|2005|254
Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy
|Canadian Journal of Cardiology|2016|234
Shared Risk Factors for Cardiovascular Disease and Cancer: Implications for Preventive Health and Clinical Care in Oncology Patients
|Canadian Journal of Cardiology|2016|173
Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy
|Echo Research and Practice|2016|56